Subject‐driven titration of biphasic insulin aspart 30 twice daily is non‐inferior to investigator‐driven titration in Chinese patients with type 2 diabetes inadequately controlled with premixed human insulin: A randomized, open‐label, parallel‐group, multicenter trial
Lists
Only you see this
Abstract
Subject-titration of BIAsp 30 BID was as efficacious and well-tolerated as investigator-titration. The present study supported patients to self-titrate BIAsp 30 BID under physicians' supervision.
BibTeX
@article{yang2015subjectdriven,
author = {Wenying Yang and Lvyun Zhu and Meng Bang-zhu and Yu Liu and Wenhui Wang and Shandong Ye and Li Sun and Heng Miao and Lian Guo and Zhanjian Wang and Xiaofeng Lv and Quanmin Li and Qiuhe Ji and Weigang Zhao and Gangyi Yang},
title = {{Subject‐driven titration of biphasic insulin aspart 30 twice daily is non‐inferior to investigator‐driven titration in Chinese patients with type 2 diabetes inadequately controlled with premixed human insulin: A randomized, open‐label, parallel‐group, multicenter trial}},
journal = {Journal of Diabetes Investigation},
year = {2015},
doi = {10.1111/jdi.12364},
}Loading related content...